Early results of aortic valve reconstruction with stentless glutaraldehyde treated autologous pericardial valve
- 46 Downloads
Aortic valve reconstruction (AoR) using single strip of autologous glutaraldehyde treated pericardium is a substitute for aortic valve replacement. We present our early results with the use of this technique.
Between November 2006 and December 2008, we successfully performed AoR with stentless glutaraldehyde treated autologous pericardial valve in 34 patients. The mitral valve was repaired in 26 of these patients. Trans-thoracic echocardiography (TTE) was performed in all patients prior to discharge and thereafter at 3 monthly intervals. Valve deterioration, thrombo-embolic complications, hemorrhage or infective complications were noted during follow-up.
There was one operative death. After mean follow-up of 16.3±8.6 months (range 4 to 29 months) low moderate to moderate AR was reported in 9 patients on TTE. AR free survival was 72.2±7.9% at a median follow-up of 14.2 months. None of the patient had any thrombo-embolic complications. None of the patients had any significant AS.
Aortic Valve reconstruction using glutaraldehyde treated autologous pericardium is feasible in young patients with acceptable results.
Key wordsMitral valve Aortic valve Echocardiography
Unable to display preview. Download preview PDF.
- 6.Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114: e84–231.CrossRefPubMedGoogle Scholar
- 10.Akins CW, Miller DC, Turina MI, et al. Councils of the American Association for Thoracic Surgery; Society of Thoracic Surgeons; European Assoication for Cardio-Thoracic Surgery; Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg 2008; 135: 732–738.CrossRefPubMedGoogle Scholar